Skip to content

HHRI News & Press Releases

HHRI News & Press Releases

Doxycycline

Doxycycline prophylaxis use low and did not prevent STIs among cisgender women

December 21, 2023

Researchers from the University of Washington (UW), Kenya Medical Research Institute (KEMRI), and Hennepin Healthcare Research Institute (HHRI) published results in the New England Journal of Medicine. The results of the study have been highly anticipated, as this is the first study of doxycycline PEP among cisgender women, following multiple…

Read More

HIV, Hepatitis B & C

July 18, 2023

Our Research Home » Our Research » HIV, Hepatitis B & C Dr. Noska’s research interests focus on clinical trials that evaluate new therapeutic agents for Hepatitis B and HIV. She investigates the social determinants of health influencing the care for persons living with HIV, HCV, and/or HBV, and comorbid…

Read More

Nephrology, Transplantation, & Health Disparities

June 12, 2023

Our Research Home » Our Research » Nephrology, Transplantation, & Health Disparities Dr. McKinney’s interests lie in researching the cause of disparities in access to kidney transplantation, evaluating patient-level barriers and facilitators to transplantation, and developing support interventions for patients and families. One of his current focuses is the joint…

Read More
Dr. Burrack Lab Photo

Dr. Burrack Bound for Homeward Bound

April 24, 2023

Growing up, Kristina Burrack, PhD, was always on the move. She was fascinated by the outdoors, loved hands-on learning, and played college athletics. Dr. Burrack loved doing science labs and knew she wanted to be a biology major in college. While at St. Olaf College, she became passionate about immunology…

Read More

STIs, HIV Prevention

April 24, 2023

Our Research Home » Our Research » STIs, HIV Prevention STIs, HIV Prevention, Clinical Trials, Behavioral Science   Jenell Stewart, DO, MPH, is an Infectious Diseases physician-scientist focused on the prevention of Sexually Transmitted Infections (STIs) and Human Immunodeficiency Virus (HIV) and improving clinical care for women who engage in transactional…

Read More
Doxycycline

Doxycycline does not prevent STIs among cisgender women

February 20, 2023

Researchers from the University of Washington (UW), Kenya Medical Research Institute (KEMRI), and Hennepin Healthcare Research Institute (HHRI) announced results at CROI from a clinical trial demonstrating that doxycycline taken after sex does not prevent bacterial sexually transmitted infections (STIs) – chlamydia or gonorrhea – among cisgender women. The dPEP…

Read More

HHRI investigators highlighted by CTSI as UMN Mothers Leading Science

January 26, 2023

Hennepin Healthcare Research Institute (HHRI) investigators Anne Frosch, MD, MPH, and Sandra Japuntich, PhD, LP, were featured in the University of Minnesota’s Clinical & Translational Science Institute (CTSI) news welcoming the fourth cohort of researcher-moms into Mothers Leading Science, a yearlong career development program for research-intensive faculty in the health sciences…

Read More

Thank you to Dr. Jason Baker for his exceptional dedication and service as HHRI Vice President

January 27, 2022

Jason Baker, MD, MS, recently stepped down as Vice President of Hennepin Healthcare Research Institute (HHRI). Dr. Baker began his tenure as VP in January 2015 when the institute was the Minneapolis Medical Research Foundation and served in the role until December 2021. During this time, Dr. Baker was instrumental…

Read More

Hennepin Healthcare launches two clinical trials to study the investigational antiviral drug remdesivir to treat hospitalized patients with COVID-19

April 9, 2020

Minneapolis, Minn. – April 9, 2020 – The Hennepin Healthcare Research Institute (HHRI) has launched two clinical trials to study the safety and efficacy of remdesivir to treat hospitalized patients diagnosed with moderate or severe COVID-19, the disease caused by the novel coronavirus SARS-CoV-2.  Hennepin Healthcare is a clinical site…

Read More
input search string and hit enter